Phlegm-Busting Drug Shows Promise in Parkinson's

13:00 EST 13 Jan 2020 | MedPageToday

]]>(MedPage Today) -- Ambroxol, a drug used in cough syrup to break up phlegm, may be worthy of further study as a neuroprotective compound in Parkinson's disease, AiM-PD trial results suggested. In a small, open-label, single-center study of Parkinson...

Original Article: Phlegm-Busting Drug Shows Promise in Parkinson's


More From BioPortfolio on "Phlegm-Busting Drug Shows Promise in Parkinson's"

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Parkinson's Disease
Parkinson's is a progressive neurological condition, affecting one person in every 500, 95% of which are over 40. It is caused by degeneration of more than 70% of the substantia nigra, which depletes the dopamine (the neurotransmitter involved in pro...